Resistant starch from high-amylose maize increases insulin sensitivity in overweight and obese men

Journal of Nutrition

Volumn 142, Issue 4, 2012, Pages 717-723

  Maki, Kevin C ^a   Pelkman, Christine L ^b   Finocchiaro, E Terry ^b   Kelley, Kathleen M ^a   Lawless, Andrea L ^a   Schild, Arianne L ^a   Rains, Tia M ^a  

^a Provident Clinical Research and Consulting Inc   (United States)

^b National Starch   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; FRUCTOSAMINE; GLUCOSAMINE; HIGH AMYLOSE MAIZE TYPE 2 RESISTANT STARCH; INSULIN; INSULIN SENSITIZING AGENT; ORAL CONTRACEPTIVE AGENT; STARCH; UNCLASSIFIED DRUG; AMYLOSE; ANTIOBESITY AGENT; DRUG DERIVATIVE; HIGH AMYLOSE MAIZE TYPE 2 RESISTANT STARCH, MAIZE; HIGH-AMYLOSE MAIZE TYPE 2 RESISTANT STARCH, MAIZE;

ABDOMINAL CRAMP; ADULT; AGED; ARTICLE; BLOATING; BLOOD LEVEL; BODY MASS; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; FEMALE; FLATULENCE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LOOSE FECES; MAIZE; MALE; NAUSEA; OBESITY; PATIENT COMPLIANCE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; UNSPECIFIED SIDE EFFECT; WAIST CIRCUMFERENCE; CARBOHYDRATE DIET; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; DIET THERAPY; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; METABOLISM; METHODOLOGY; MIDDLE AGED; PLANT SEED; SEXUAL DEVELOPMENT;

ZEA MAYS;

ADULT; AMYLOSE; ANTI-OBESITY AGENTS; BODY MASS INDEX; CROSS-OVER STUDIES; DIETARY CARBOHYDRATES; DOUBLE-BLIND METHOD; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; SEEDS; SEX CHARACTERISTICS; STARCH; WAIST CIRCUMFERENCE; ZEA MAYS;

EID: 84861121083     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.111.152975     Document Type: Article

References (51)

1. Englyst H, Wiggins HS, Cummings JH. Determination of the non-starch polysaccharides in plant foods by gas-liquid chromatography of constituent sugars as alditol acetates. Analyst. 1982;107:307-18.
2. Englyst HN, Kingman SM, Cummings JH. Classification and measurement of nutritionally important starch fractions. Eur J Clin Nutr. 1992;46 Suppl 2:S33-50.
3. Finocchiaro ET, Birkett AM, Okoniewska M. Resistant starch. In: S Cho, P Samuel, editors. Fiber ingredients: food applications and health benefits. Boca Raton (FL): CRC Press; 2000.
4. Brown MA, Storlien LH, Brown IL, Higgins JA. Cooking attenuates the ability of high-amylose meals to reduce plasma insulin concentrations in rats. Br J Nutr. 2003;90:823-7.
5. Murphy MM, Douglass JS, Birkett A. Resistant starch intakes in the United States. J Am Diet Assoc. 2008;108:67-78.
6. Asp NG, van Amelsvoort JM, Hautvast JG. Nutritional implications of resistant starch. Nutr Res Rev. 1996;9:1-31.
7. Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev. 2001;81:1031-64.
8. Nugent AP. Health properties of resistant starch. Nutr Bull. 2005;30:27-54.
9. Miller Jones J, Witwer R, Birkett A. High amylose corn resistant starch monograph [N Starch, editor], 2005. Available from: www.resistantstarch. com.
10. Birkett A, Muir J, Phillips J, Jones G, O'Dea K. Resistant starch lowers fecal concentrations of ammonia and phenols in humans. Am J Clin Nutr. 1996;63:766-72.
11. Muir JG, Yeow EG, Keogh J, Pizzey C, Bird AR, Sharpe K, O'Dea K, Macrae FA. Combining wheat bran with resistant starch has more beneficial effects on fecal indexes than does wheat bran alone. Am J Clin Nutr. 2004;79:1020-8.
12. Noakes M, Clifton PM, Nestel PJ, Le Leu R, McIntosh G. Effect of high-amylose starch and oat bran on metabolic variables and bowel function in subjects with hypertriglyceridemia. Am J Clin Nutr. 1996;64:944-51.
13. Phillips J, Muir JG, Birkett A, Lu ZX, Jones GP, O'Dea K, Young GP. Effect of resistant starch on fecal bulk and fermentation-dependent events in humans. Am J Clin Nutr. 1995;62:121-30.
14. Johnston KL, Thomas EL, Bell JD, Frost GS, Robertson MD. Resistant starch improves insulin sensitivity in metabolic syndrome. Diabet Med. 2010;27:391-7.
15. Robertson MD, Currie JM, Morgan LM, Jewell DP, Frayn KN. Prior short-term consumption of resistant starch enhances postprandial insulin sensitivity in healthy subjects. Diabetologia. 2003;46:659-65.
16. Robertson MD, Bickerton AS, Dennis AL, Vidal H, Frayn KN. Insulinsensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism. Am J Clin Nutr. 2005;82: 559-67.
17. Tarini J, Wolever TM. The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects. Appl Physiol Nutr Metab. 2010;35:9-16.
18. Higgins JA. Resistant starch: metabolic effects and potential health benefits. J AOAC Int. 2004;87:761-8.
19. Ferrannini E, Barrett EJ, Bevilacqua S, DeFronzo RA. Effect of fatty acids on glucose production an utilization in man. J Clin Invest. 1983;72:1737-47.
20. Cusi K, Kashyap S, Gastaldelli A, Bajaj M, Cersosimo E. Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetes. Am J Physiol Endocrinol Metab. 2007;292: E1775-81.
21. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunningshake DB, Pasternak RC, Smith SC Jr, Stone NJ, National Heart Lung, and Blood Institute, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227-39.
22. Bergman RN, Kim SP, Hsu IR, Catalano KJ, Chiu JD, Kabir M, Richey JM, Ader M. Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk. Am J Med. 2007;120 (2 Suppl 1):S3-8; discussion S29-32.
23. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation. 2002;106:3143-421.
24. Merrill AL, Watt BK. Energy value of foods: basis and derivation. Agriculture handbook 74. Washington, DC: USDA, Agricultural Research Service; 1973.
25. Maki KC, Carson ML, Miller MP, Turowski M, Bell M, Wilder DM, Reeves MS. High-viscosity hydroxypropylmethylcellulose blunts postprandial glucose and insulin responses. Diabetes Care. 2007;30: 1039-43.
26. Bergman RN, Prager R, Volund A, Olefsky JM. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest. 1987;79:790-800.
27. Diabetes Trials Unit [Internet]. The Oxford Centre for Diabetes, Endocrinology and Metabolism [cited 2011 Dec 21]. Available from: http://www.dut.ox.ac.uk.
28. Kadish AH, Hall DA. A new method for the continuous monitoring of blood glucose by measurement of dissolved oxygen. Clin Chem. 1965;11:869-75.
29. Allauzen S, Mani JC, Granier C, Pau B, Bouanani M. Epitope mapping and binding analysis of insulin-specific monoclonal antibodies using a biosensor approach. J Immunol Methods. 1995;183:27-32.
30. Melzi d'Eril GV, Bosoni T, Solerte SB, Fioravanti M, Ferrari E. Performance and clinical significance of the new fructosamine assay in diabetic patients. Wien Klin Wochenschr Suppl. 1990;180:60-3.
31. Murase M, Kimura Y, Nagata Y. Determination of portal short-chain fatty acids in rats fed various dietary fibers by capillary gas chromatography. J Chromatogr B Biomed Appl. 1995;664:415-20.
32. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of LDL cholesterol in plasma without use of a preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
33. Penn-Marshall M, Holtzman GI, Barbeau WE. African Americans may have to consume more than 12 grams a day of resistant starch to lower their risk for type 2 diabetes. J Med Food. 2010;13:999-1004.
34. Dubé JJ, Amati F, Toledo FG, Stefanovic-Racic M, Rossi A, Coen P, Goodpaster BH. Effects of weight loss and exercise on insulin resistance, and intramyocellular triacylglycerol, diacylglycerol and ceramide. Diabetologia. 2011;54:1147-56.
35. Viljanen AP, Iozzo P, Borra R, Kankaanpää M, Karmi A, Lautamäki R, Järvisalo M, Parkkola R, Rönnemaa T, Guiducci L, et al. Effect of weight loss on liver free fatty acid uptake and hepatic insulin resistance. J Clin Endocrinol Metab. 2009;94:50-5.
36. Toledo FG, Menshikova EV, Ritov VB, Azuma K, Radikova Z, DeLany J, Kelley DE. Effects of physical activity and weight loss on skeletal muscle mitochondria and relationship with glucose control in type 2 diabetes. Diabetes. 2007;56:2142-7.
37. Bajaj M, Suraamornkul S, Kashyap S, Cusi K, Mandarino L, DeFronzo RA. Sustained reduction in plasma free fatty acid concentration improves insulin action without altering plasma adipocytokine levels in subjects with strong family history of type 2 diabetes. J Clin Endocrinol Metab. 2004;89:4649-55.
38. Burns SF, Kelsey SF, Arslanian SA. Effects of an intravenous lipid challenge and free fatty acid elevation on in vivo insulin sensitivity in African American versus Caucasian adolescents. Diabetes Care. 2009;32:355-60.
39. McGarry JD. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes. 2002;51:7-18.
40. Mathew M, Tay E, Cusi K. Elevated plasma free fatty acids increase cardiovascular risk by inducing plasma biomarkers of endothelial activation, myeloperoxidase and PAI-1 in healthy subjects. Cardiovasc Diabetol. 2010;9:9.
41. Høeg LD, Sjøberg KA, Jeppesen J, Jensen TE, Frøsig C, Birk JB, Bisiani B, Hiscock N, Pilegaard H, Wojtaszewski JF, et al. Lipid-induced insulin resistance affects women less than men and is not accompanied by inflammation or impaired proximal insulin signaling. Diabetes. 2011;60:64-73.
42. Kim SP, Catalano KJ, Hsu IR, Chiu JD, Richey JM, Bergman RN. Nocturnal free fatty acids are uniquely elevated in the longitudinal development of diet-induced insulin resistance and hyperinsulinemia. Am J Physiol Endocrinol Metab. 2007;292:E1590-8.
43. Santomauro AT, Boden G, Silva ME, Rocha DM, Santos RF, Ursich MJ, Strassmann PG, Wajchenberg BL. Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diabetes. 1999;48:1836-41.
44. Degen LP, Phillips SF. Variability of gastrointestinal transit in healthy women and men. Gut. 1996;39:299-305.
45. El Oufir L, Flourié B, Bruley des Varannes S, Barry JL, Cloarec D, Bornet F, Galmiche JP. Relations between transit time, fermentation products, and hydrogen consuming flora in healthy humans. Gut. 1996;38:870-7.
46. Weickert MO, Möhlig M, Schöfl C, Arafat AM, Otto B, Viehoff H, Koebnick C, Kohl A, Spranger J, Pfeiffer AF. Cereal fiber improves whole-body insulin sensitivity in overweight and obese women. Diabetes Care. 2006;29:775-80.
47. McBurney MI. Starch malabsorption and stool excretion are influenced by the menstrual cycle in women consuming low-fibre Western diets. Scand J Gastroenterol. 1991;26:880-6.
48. Hallfrisch J, Behall KM. Breath hydrogen and methane responses of men and women to breads made with white flour or whole wheat flours of different particle sizes. J Am Coll Nutr. 1999;18:296-302.
49. Escalante Pulido JM, Alpizar Salazar M. Changes in insulin sensitivity, secretion and glucose effectiveness during menstrual cycle. Arch Med Res. 1999;30:19-22.
50. Yeung EH, Zhang C, Mumford SL, Ye A, Trevisan M, Chen L, Browne RW, Wactawski-Wende J, Schisterman EF. Longitudinal study of insulin resistance and sex hormones over the menstrual cycle: the BioCycle Study. J Clin Endocrinol Metab. 2010;95:5435-42.
51. Bingley CA, Gitau R, Lovegrove JA. Impact of menstrual cycle phase on insulin sensitivity measures and fasting lipids. Horm Metab Res. 2008;40:901-6.